July 19 (Reuters) - The head of the U.S. agency responsible for animal welfare has told lawmakers that it did not find any violations of animal research rules at Elon Musk's Neuralink beyond a 2019 incident the brain implant company had already reported.
The inspection included visits at Neuralink's two facilities in January 2023, Vilsack wrote, adding that there would be more inspections.
Vilsack said in his letter his agency did not include in its inspection citations an "adverse surgical event" at Neuralink that occurred in August 2019.
The company proactively reported it and took corrective action, which complied with the policy at the time, Vilsack added.
The mistakes weakened the experiments' research value and required the tests to be repeated, leading to more animals being killed.
Persons:
Thomas Vilsack, Earl Blumenauer, Vilsack, Musk, Neuralink, Blumenauer, Ryan Merkley, Marisa Taylot, Greg Roumeliotis, Robert Birsel
Organizations:
U.S, Elon Musk's, Department of Agriculture, Reuters, USDA, Physicians, Responsible Medicine, Neuralink, University of California, UC Davis, Drug Administration, FDA, Department of Transportation, Washington , D.C, Thomson
Locations:
Neuralink, Davis, Washington ,